Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online May 9, 2008
Diabetes 57:2137-2148, 2008
DOI: 10.2337/db07-1631
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db07-1631v1
57/8/2137    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Wang, Z. V.
Right arrow Articles by Scherer, P. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Z. V.
Right arrow Articles by Scherer, P. E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

PANIC-ATTAC: A Mouse Model for Inducible and Reversible β-Cell Ablation

Zhao V. Wang1,2,3, James Mu4, Todd D. Schraw2,3, Laurent Gautron2,5,6, Joel K. Elmquist2,5,6, Bei B. Zhang4, Michael Brownlee7, and Philipp E. Scherer2,3

1 Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York
2 Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas
3 Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, Texas
4 Department of Metabolic Disorders, Merck Research Laboratories, Rahway, New Jersey
5 Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas
6 Division of Hypothalamic Research, University of Texas Southwestern Medical Center, Dallas, Texas
7 Department of Medicine and Diabetes Research Center, Albert Einstein College of Medicine, Bronx, New York

Corresponding author: Philipp E. Scherer, philipp.scherer{at}utsouthwestern.edu

OBJECTIVE—Islet transplantations have been performed clinically, but their practical applications are limited. An extensive effort has been made toward the identification of pancreatic β-cell stem cells that has yielded many insights to date, yet targeted reconstitution of β-cell mass remains elusive. Here, we present a mouse model for inducible and reversible ablation of pancreatic β-cells named the PANIC-ATTAC (pancreatic islet β-cell apoptosis through targeted activation of caspase 8) mouse.

RESEARCH DESIGN AND METHODS—We efficiently induce β-cell death through apoptosis and concomitant hyperglycemia by administration of a chemical dimerizer to the transgenic mice. In contrast to animals administered streptozotocin, the diabetes phenotype and β-cell loss are fully reversible in the PANIC-ATTAC mice, and we find significant β-cell recovery with normalization of glucose levels after 2 months.

RESULTS—The rate of recovery can be enhanced by various pharmacological interventions with agents acting on the glucagon-like peptide 1 axis and agonists of peroxisome proliferator–activated receptor-{gamma}. During recovery, we find an increased population of GLUT2+/insulin cells in the islets of PANIC-ATTAC mice, which may represent a novel pool of potential β-cell precursors.

CONCLUSIONS—The PANIC-ATTAC mouse may be used as an animal model of inducible and reversible β-cell ablation and therefore has applications in many areas of diabetes research that include identification of β-cell precursors, evaluation of glucotoxicity effects in diabetes, and examination of pharmacological interventions.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.